First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel.
about
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug DeliveryBiodegradable double nanocapsule as a novel multifunctional carrier for drug delivery and cell imagingPhase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy.Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.A retrospective analysis of safety and efficacy of weekly nab-paclitaxel as second-line chemotherapy in elderly patients with advanced squamous non-small-cell lung carcinoma.244-MPT overcomes gefitinib resistance in non-small cell lung cancer cellsPaclitaxel-loaded phosphonated calixarene nanovesicles as a modular drug delivery platform.Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancerDeguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1.Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors.Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy.Mechanism of Action of the Anti-Inflammatory Connexin43-Mimetic Peptide JM2.Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis.Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease.Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive AgentsThe role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China.
P2860
Q28076132-6EE89669-A90D-4126-8537-7E952FB7E2F5Q28397490-4694CE84-1C0A-4741-949D-C00D2566592AQ33442004-B1439C57-97A0-4AD6-934A-1362CFF9F126Q36036923-079076FE-2E8C-4D96-A379-CCB911F36D24Q36109555-29CD4C66-A4DD-4F7D-85E7-F82C5057F704Q36617748-30ED7D42-D7B2-4B4C-A74A-698D454BB4E5Q36688956-35C4751F-5AAB-467F-836A-B26BE1E343C9Q36724789-FCC15E73-D5F3-4C69-B8F8-4910FB83D9C8Q36740905-99349ECF-0160-4EC1-9FF1-C09EE741C1DFQ37012150-2ED26DDF-0AF8-40C3-9AFE-6216A940DB6BQ37399257-D6BA637E-FCF8-43BC-8F07-DA975A443004Q37594238-1F61D7A5-1C15-43B1-B5AF-1AE82DC19F9CQ38682090-DE45EC3E-45DD-4978-9536-74B9CB2483FCQ39735209-D0CB7ECE-6C3B-456B-B134-A10E9DA31041Q42376439-02F84276-36DF-4D35-A624-32498AA595C5Q42755952-7BCE82F9-72EE-4303-8926-698A6C9AF25CQ47100701-6C57E822-0A40-4128-AD30-2609AF33653A
P2860
First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
First line treatment of advanc ...... s on albumin bound paclitaxel.
@en
First line treatment of advanc ...... s on albumin bound paclitaxel.
@nl
type
label
First line treatment of advanc ...... s on albumin bound paclitaxel.
@en
First line treatment of advanc ...... s on albumin bound paclitaxel.
@nl
prefLabel
First line treatment of advanc ...... s on albumin bound paclitaxel.
@en
First line treatment of advanc ...... s on albumin bound paclitaxel.
@nl
P2093
P2860
P921
P356
P1476
First line treatment of advanc ...... s on albumin bound paclitaxel.
@en
P2093
Grace K Dy
Hassan Hatoum
Neha Gupta
P2860
P304
P356
10.2147/IJN.S41770
P407
P5008
P577
2013-12-24T00:00:00Z